Planning

Respiratory Transformation Partnership

OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

This public procurement record has 1 release in its history.

Planning

15 Sep 2025 at 16:15

Planning Notice
Summary of the contracting process

The "Respiratory Transformation Partnership" procurement process, initiated by the Oxford University Hospitals NHS Foundation Trust, focuses on the medical practice services industry. It is part of a broader programme led by the Health Innovation Oxford and Thames Valley (HIOTV) in the UK. Currently at the planning stage, this engagement aims to address respiratory health challenges associated with asthma and COPD. A Prior Information Notice has been issued to reach potential industry partners interested in collaborating. Key dates include the planned engagement meetings between 1st and 10th October 2025, with responses to a Questionnaire due by 29th September 2025. This initiative does not represent a direct procurement opportunity but seeks input to shape future strategies and models related to respiratory care innovation.

Businesses operating within the field of respiratory medicines, diagnostics, or digital health solutions have the opportunity to engage with the NHS and potentially influence future healthcare policies and strategies in this sector. Firms with innovative solutions for asthma and COPD will find this market engagement particularly beneficial to showcase their contributions and collaborate with public health stakeholders. Although this is not a direct call for competition, it provides an avenue for industry players to interface with the NHS, paving the way for future procurement processes and potential collaborations. Organisations with a focus on improving respiratory care pathways or enhancing the innovation pipeline in the UK are well-suited to participate.

How relevant is this notice?

Notice Information

Notice Title

Respiratory Transformation Partnership

Notice Description

Health Innovation Oxford and Thames Valley ("HIOTV") is conducting this market engagement ("Engagement") as part of the Health Innovation Network(HIN)-led Respiratory Transformation Programme

Lot Information

Lot 1

Asthma and chronic obstructive pulmonary disease (COPD) together affect millions of people across England and are responsible for a high burden of avoidable hospital admissions, significant health inequalities, and substantial costs to the NHS. Despite advances in medicines, inhaler technologies, diagnostics, and digital tools, uptake and equitable access to innovation and outcomes in respiratory care remains inconsistent. This engagement represents an opportunity for industry partners to come together with the NHS to explore how innovative medicines, devices, diagnostics and digital solutions can be safely and effectively introduced into asthma and COPD pathways. The aim is to accelerate access to innovation, improve respiratory outcomes, and support the delivery of more sustainable models of care. The objectives of this engagement are to: - Identify and engage potential industry partners with innovative asthma and COPD medicines (including biologics and inhaled therapies) that could support the Respiratory Transformation Partnership. - Recognise innovations in diagnostics, devices and digital tools where these directly enable or enhance the uptake, safe use, and equitable access to respiratory medicines. - Understand potential forms of contribution from industry partners on anon-exclusive basis, - Take stock of the medicine innovation landscape and pipeline to inform Health Innovation Network support for innovators and to shape future partnership models. This is not a call for competition and there is no planned procurement activity or funding available for potential partners at this stage. Insights gathered will be used to shape future policy, strategy and potential partnership models. HIOTV are making use of the Atamis/FTS channel as the existing infrastructure to maximise potential engagement, and have chosen to issue this as a Prior Information Notice as it is the most appropriate notice type to ensure maximum reach. To reiterate, no public contracts will be awarded as a direct result of this engagement. Participation HIOTV is inviting organisations who meet the following Eligibility Criteria: - organisations that are currently marketing asthma or COPD medicines in the UK, or that have such medicines in development with a marketing authorisation for UK use likely to besought within the next three years. - organisations innovations likely to improve access to innovative medicines or improve care pathways for asthma and COPD patients are also welcome to contribute. HIOTV is offering the opportunity for Respondents to: - Complete an online Questionnaire("Questionnaire"); and - If deemed appropriate attend a one-to-one Engagement Meeting to assesspotential areas of partnership Engagement meetings are expected to be held between 1st October and 10thOctober 2025. HIOTV will use reasonable endeavours to accommodate all interested respondents within this window. Additional information: All Respondents will be asked to complete a Questionnaire, accessible on request from hin-rtp@healthinnovationoxford.org Respondents may also submit additional documents as part of their Response. Individual survey responses will be only made available to teams developing the Respiratory Transformation Partnership within HIOTV and the Office for LifeScience. A summary of insights (non-attributable and anonymised) will be published on the Atamis portal. Further phases of consultation may be planned during 2025 in respect of enabling access to innovative medicines and technologies for asthma and COPD. You can opt-in to be notified of these opportunities via the Questionnaire and/or by contacting HIOTV at: hin-rtp@healthinnovationoxford.org Responses to the Questionnaire should be submitted by 29th Sept 2025.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-059ab7
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/056731-2025
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85121000 - Medical practice services

Notice Value(s)

Tender Value
£1
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
15 Sep 20252 months ago
Submission Deadline
Not specified
Future Notice Date
15 Sep 2025Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
Contact Name
Samantha Collins
Contact Email
samantha.collins@healthinnovationoxford.org
Contact Phone
Not specified

Buyer Location

Locality
OXFORD
Postcode
OX3 9DU
Post Town
Oxford
Country
England
Major Region (ITL 1)
TLJ South East (England)
Basic Region (ITL 2)
TLJ1 Berkshire, Buckinghamshire and Oxfordshire
Small Region (ITL 3)
TLJ14 Oxfordshire CC
Delivery Location
Not specified
Local Authority
Oxford
Electoral Ward
Headington Hill & Northway
Westminster Constituency
Oxford East

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-059ab7-2025-09-15T17:15:33+01:00",
    "date": "2025-09-15T17:15:33+01:00",
    "ocid": "ocds-h6vhtk-059ab7",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-059ab7",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Respiratory Transformation Partnership",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "85121000",
            "description": "Medical practice services"
        },
        "mainProcurementCategory": "services",
        "description": "Health Innovation Oxford and Thames Valley (\"HIOTV\") is conducting this market engagement (\"Engagement\") as part of the Health Innovation Network(HIN)-led Respiratory Transformation Programme",
        "value": {
            "amount": 1,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "Asthma and chronic obstructive pulmonary disease (COPD) together affect millions of people across England and are responsible for a high burden of avoidable hospital admissions, significant health inequalities, and substantial costs to the NHS. Despite advances in medicines, inhaler technologies, diagnostics, and digital tools, uptake and equitable access to innovation and outcomes in respiratory care remains inconsistent. This engagement represents an opportunity for industry partners to come together with the NHS to explore how innovative medicines, devices, diagnostics and digital solutions can be safely and effectively introduced into asthma and COPD pathways. The aim is to accelerate access to innovation, improve respiratory outcomes, and support the delivery of more sustainable models of care. The objectives of this engagement are to: - Identify and engage potential industry partners with innovative asthma and COPD medicines (including biologics and inhaled therapies) that could support the Respiratory Transformation Partnership. - Recognise innovations in diagnostics, devices and digital tools where these directly enable or enhance the uptake, safe use, and equitable access to respiratory medicines. - Understand potential forms of contribution from industry partners on anon-exclusive basis, - Take stock of the medicine innovation landscape and pipeline to inform Health Innovation Network support for innovators and to shape future partnership models. This is not a call for competition and there is no planned procurement activity or funding available for potential partners at this stage. Insights gathered will be used to shape future policy, strategy and potential partnership models. HIOTV are making use of the Atamis/FTS channel as the existing infrastructure to maximise potential engagement, and have chosen to issue this as a Prior Information Notice as it is the most appropriate notice type to ensure maximum reach. To reiterate, no public contracts will be awarded as a direct result of this engagement. Participation HIOTV is inviting organisations who meet the following Eligibility Criteria: - organisations that are currently marketing asthma or COPD medicines in the UK, or that have such medicines in development with a marketing authorisation for UK use likely to besought within the next three years. - organisations innovations likely to improve access to innovative medicines or improve care pathways for asthma and COPD patients are also welcome to contribute. HIOTV is offering the opportunity for Respondents to: - Complete an online Questionnaire(\"Questionnaire\"); and - If deemed appropriate attend a one-to-one Engagement Meeting to assesspotential areas of partnership Engagement meetings are expected to be held between 1st October and 10thOctober 2025. HIOTV will use reasonable endeavours to accommodate all interested respondents within this window. Additional information: All Respondents will be asked to complete a Questionnaire, accessible on request from hin-rtp@healthinnovationoxford.org Respondents may also submit additional documents as part of their Response. Individual survey responses will be only made available to teams developing the Respiratory Transformation Partnership within HIOTV and the Office for LifeScience. A summary of insights (non-attributable and anonymised) will be published on the Atamis portal. Further phases of consultation may be planned during 2025 in respect of enabling access to innovative medicines and technologies for asthma and COPD. You can opt-in to be notified of these opportunities via the Questionnaire and/or by contacting HIOTV at: hin-rtp@healthinnovationoxford.org Responses to the Questionnaire should be submitted by 29th Sept 2025.",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2025-09-16T00:00:00+01:00"
        },
        "coveredBy": [
            "GPA"
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-160935",
            "name": "Oxford University Hospitals NHS Foundation Trust",
            "identifier": {
                "legalName": "Oxford University Hospitals NHS Foundation Trust",
                "noIdentifierRationale": "notOnAnyRegister"
            },
            "address": {
                "streetAddress": "John Radcliffe Hospital, Headley Way",
                "locality": "Oxford",
                "region": "UKJ14",
                "postalCode": "OX39DU",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Samantha Collins",
                "email": "samantha.collins@healthinnovationoxford.org"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.ouh.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-160935",
        "name": "Oxford University Hospitals NHS Foundation Trust"
    },
    "language": "en"
}